Government Recombinant Online Tenders from 2026

Corrigendum: Recombinant Human Epidermal Growth Tube of 15gm, Qty: 15 Tube, (BOQ Item #10)

Corrigendum: Erythropoitein human Recombinant 2000 IU Inj, Qty: 150 Vial, (BOQ Item #35)

Corrigendum: Human insulin Analogue long acting Ingcomma10, Qty: 390 PFS, (BOQ Item #42)

Corrigendum: Inj Degludec Insulin Aspart Recombinant DNA origin 70 Percent Insulin Degludec and 30 Percent Insulin Aspart 100 U per ml 3 ml, Qty: 800 Cart, (BOQ Item #4)

Corrigendum: Inj Human Insulin Analogue Aspart Premix 30 Percent Insulin and 70 Percent Insulin Protamine Aspart suspension 100 IU Per ml Monocomponent Insulin,recombinant DNA origin 3 ml PFS or PFP, Qty: 600 PFS OR PFP, (BOQ Item #2)

Corrigendum: Inj Human Insulin Analogue Aspart Premix 30 percent Insulin 70 percent Insulin Protamine Aspart suspension 100 IU ml Monocomponent Insulin recombinant DNA origin 3 ml PFS PFP, Qty: 1220 PFS PFP, (BOQ Item #3)

Inj Erythropoietin Recombinant Human 6000 Iu, Qty: 30 No, (BOQ Item #158)

Regen D Recombinant Human Epidermal growth Factor 150 MCG15 GM, Qty: 120 TUBE, (BOQ Item #55)

Recombinant Factor VIII Injection 500 IU, Qty: 300 NA, (BOQ Item #1)

Corrigendum: Inj Lutropin Alpha r DNA Recombinant Leutinising Hormone 75 IU, Qty: 150 VIAL, (BOQ Item #14)